Dana Sun

Principal

2023 - Current

We back Seed, Series A, and Series B digital health, tech-enabled services, and medical device companies around the world that maximize direct life-saving impact.

Senior Associate, Digital Health

2021 - 2023

Focus on Seed and Series A investments in health technology, tech-enabled healthcare services, and diagnostics companies. Companies I work with: - eBlu Solutions: Benefits verification & prior authorization for specialty medication - Biotia: AI-driven solutions to diagnose and control infectious diseases - HealtheMed: Clinic at home for Medicaid special needs population - Amplified Sciences: Diagnostics platform for accurate detection of cancers - iPill: Smart dispenser & companion app for improving prescription adherence and reducing opioid abuse - Rhythm Science: Integrated software platform for cardiac data management across hypertension, heart failure, and rhythm disorders - Atalan Tech: Applying machine learning to predict and prevent clinician burnout and turnover at health systems

Venture Fellow

2020 - 2021

Strategic Finance

2020 - 2021

At Genentech / Roche, I was part of the Center of Financial Insights (CoFI) driving commercial insights across our therapeutic portfolio for global affiliates.

Venture Capital Associate

2019 - 2020

Growth Strategy

2019 - 2019

‘87 is the venture arm of Sterling Partners, a multi-strategy investment firm. ‘87 incubates direct to consumer startups through funding, technology, talent, content development, and infrastructure.

Management Consultant

2016 - 2018

Senior Business Analyst

2015 - 2016

Business Analyst

2014 - 2015